Table 1.
Studies reporting on results of corticosteroid monotherapy in patients presenting with initial-onset Vogt-Koyanagi-Harada disease
| Author | Country | Year | Number of patients | Treatment | Number of patients with chronicity (%) | Number of patients with SGF (%) |
|---|---|---|---|---|---|---|
| Series of initial-onset VKH patients treated only with corticosteroids | ||||||
| Rubsamen and Gass15 | USA | 1991 | 19 | CS | 19 (100) | N/A |
| Nishioka et al.16 | Japan | 1995 | 87 | CS | 29 (33) | N/A |
| Keino et al.17 | Japan | 2002 | 80 | CS | 14 (18) | 54 (68) |
| Keino et al.18 | Japan | 2006 | 102 | CS | N/A | 69 (68) |
| Tugal-Tutkun et al.19 | Turkey | 2007 | 19 | CS | 18 (95) | 14 (74) |
| Khairallah et al.20 | Tunisia | 2007 | 38 | CS | 23 (61) | N/A |
| Chee et al.21 | Singapore | 2007 | 39 | CS | 18 (49) | N/A |
| Lai et al.22 | Hong-Kong | 2009 | 35 | CS | 12 (34) | 18 (51) |
| Cuchacovich et al.23 | Chile | 2010 | 44 | CS | 21 (48) | N/A |
| Errera et al.24 | France | 2011 | 42 | CS | 31 (73) | |
| Abu El-Asrar et al.25 | Saudi Arabia | 2013 | 28 | CS | 19 (68) | 13 (46) |
| Ozdal et al.26 | Turkey | 2014 | 16 | CS | 7 (44) | 7 (44) |
| Iwahashi et al.27 | Japan | 2015 | 55 | CS | 14 (26) | N/A |
| Sakata et al.13 | Brazil | 2015 | 29 | CS | 23 (79) | N/A |
| Giordano et al.28 | Argentina | 2017 | 58 | CS | 33 (57) | N/A |
| Nakayama et al.29 | Japan | 2019 | 111 | CS | 25 (23) | 55 (50) |
| Total | 802 | CS | 306/700=44% | 230/391=59% | ||
SGF: Sunset-glow fundus, VKH: Vogt-Koyanagi-Harada, CS: Corticosteroid, N/A: Not available